Main Menu

MSK Announces Closing of Financing for NASDAQ Client RGDX

September 3, 2014

Mitchell, Silberberg & Knupp* announced that its client Response Genetics, Inc. (NASDAQ: RGDX) entered into and completed the initial drawdown of a $12 million credit facility from SWK Funding LLC, a wholly-owned subsidiary of SWK Holdings Corporation.

The Mitchell, Silberberg & Knupp* team was led by Co-Managing Partner, Kevin Friedmann. Response Genetics is a CLIA-certified clinical laboratory focused on the development and sale of molecular diagnostic testing services for cancer. 

*Handled through the predecessor law firm of Richardson Patel LLP.

Back to Page